1. Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer☆. (February 2016) Authors: Hames, Megan L.; Chen, Heidi; Iams, Wade; Aston, Jonathan; Lovly, Christine M.; Horn, Leora Journal: Lung cancer Issue: Volume 92(2016) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of Concomitant pH‐Elevating Medications with Pazopanib on Progression‐Free Survival and Overall Survival in Patients with Metastatic Renal Cell Carcinoma. (27th February 2018) Authors: McAlister, Renee K.; Aston, Jonathan; Pollack, Megan; Du, Liping; Koyama, Tatsuki; Chism, David D. Journal: Oncologist Issue: Volume 23:Number 6(2018) Page Start: 686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prognostic Impact of KRAS Mutation Subtypes in 677 Patients with Metastatic Lung Adenocarcinomas. Issue 3 (March 2015) Authors: Yu, Helena A.; Sima, Camelia S.; Shen, Ronglai; Kass, Samantha; Gainor, Justin; Shaw, Alice; Hames, Megan; Iams, Wade; Aston, Jonathan; Lovly, Christine M.; Horn, Leora; Lydon, Christine; Oxnard, Geoffrey R.; Kris, Mark G.; Ladanyi, Marc; Riely, Gregory J. Journal: Journal of thoracic oncology Issue: Volume 10:Issue 3(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Talimogene laherparepvec in advanced melanoma. (2nd July 2016) Authors: Pollack, Megan H.; Aston, Jonathan; Benrashid, Mona; Johnson, Douglas B.; Puzanov, Igor Journal: Expert opinion on orphan drugs Issue: Volume 4:Number 7(2016:Jul.) Page Start: 781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗